Alfuzosin;Silodosin;Tamsulosin/Protease Inhibitors Interactions
This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or commencing any course of treatment.
Severe. These medicines may interact and cause very harmful effects and are usually not taken together. Contact your healthcare professional (e.g. doctor or pharmacist) for more information.
How the interaction occurs:
Your protease inhibitor may slow down how quickly your liver processes alfuzosin, silodosin, and tamsulosin.
What might happen:
The amount of alfuzosin, silodosin, or tamsulosin in your blood may increase. You may experience dizziness, fatigue, or fainting.
What you should do about this interaction:
Let your healthcare professionals (e.g. doctor or pharmacist) know right away that you are taking these medicines together. Tell your doctor if you experience any dizziness, fatigue, or fainting.Your healthcare professionals may already be aware of this interaction and may be monitoring you for it. Do not start, stop, or change the dosage of any medicine before checking with them first.
- 1.Uroxatral (alfuzosin hydrochloride) US prescribing information. Sanofi-Synthelabo, Inc. May, 2013.
- 2.Rapaflo (silodosin) US prescribing information. Watson Laboratories, Inc. July, 2013.
- 3.Flomax (tamsulosin hydrochloride) US prescribing information. Boehringer Ingelheim Pharmaceuticals, Inc. October 20. 2014.
- 4.Reyataz (atazanavir sulfate) US prescribing information. Bristol-Myers Squibb Company March, 2018.
- 5.Prezista (darunavir) US prescribing information. Tibotec Inc. May, 2019.
- 6.Lexiva (fosamprenavir calcium) US prescribing information. GlaxoSmithKline March, 2019.
- 7.Crixivan (indinavir sulfate) US prescribing information. Merck & Co., Inc. September, 2016.
- 8.Kaletra (lopinavir/ritonavir tablets) US prescribing information. Abbott Laboratories December, 2019.
- 9.Viracept (nelfinavir mesylate) US prescribing information. Agouron Pharmaceuticals, Inc. September, 2016.
- 10.Norvir (ritonavir) US prescribing information. Abbott Laboratories December, 2019.
- 11.Invirase (saquinavir mesylate) US prescribing information. Roche Laboratories, Inc. March, 2019.
- 12.Aptivus (tipranavir) US prescribing information. Boehringer Ingelheim Pharmaceuticals, Inc. June, 2018.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.